Jones Trading Initiates Coverage On Azora Therapeutics with Buy Rating, Announces Price Target of $14

Benzinga · 2d ago
Jones Trading analyst Debanjana Chatterjee initiates coverage on Azora Therapeutics (NASDAQ:AZR) with a Buy rating and announces Price Target of $14.